Form 4: Charles River Labs Director Richard Wallman Reports Stock Sales
SEC Form 4
Director Richard Wallman reported the disposition of Charles River Laboratories (CRL) shares through sales and a gift, according to a Form 4 filing.
Summary
- Richard F. Wallman, a director of Charles River Laboratories International, Inc. (CRL), filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On November 6, 2024, Wallman gifted 4,540 shares of common stock.
- On November 7, 2024, Wallman sold 3,371 shares at $215.75, 3,250 shares at $216.5, and 1,000 shares at $216.5.
- Following these transactions, Wallman directly owns 12,386 shares and indirectly owns 0 shares through his wife.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider. It provides transparency to the market regarding the buying and selling activities of key personnel.
Stakeholder Impact
- The stock sales by a director could be perceived negatively by shareholders, although such transactions are common and don't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 11/06/2024 | Richard Wallman gifted 4,540 shares of common stock. |
| 11/07/2024 | Richard Wallman sold 3,371 shares at $215.75, 3,250 shares at $216.5, and 1,000 shares at $216.5. |
| 11/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.